According to the Associated Press news agency, four patients received a coronavirus jab at the Kaiser Permanente research facility in Seattle, Washington,
The first person to get the jab on Monday was a 43-year-old mother-of-two from Seattle.
“This is an amazing opportunity for me to do something,” Jennifer Haller told AP.
This first human trial, funded by the National Institutes of Health, sidesteps a check that would normally be conducted to ensure sure the vaccine can trigger an immune response in animals.
The vaccine cannot contain a harmless genetic code copied from the virus that causes the disease.
However, the vaccine will still take months to know if this will work effectively, say experts.
(With inputs from Agencies)
Comment